XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.1
Stock Based Compensation Plans
9 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Stock Based Compensation Plans

NOTE 10 – STOCK BASED COMPENSATION PLANS

 

The Company follows Accounting Standard Codification (ASC) Topic 718 “Compensation – Stock Compensation”, which addresses accounting for equity-based compensation arrangements, including employee stock options and restricted stock units.

 

Please refer to Note 16 – Stock Based Compensation Plans in the Company’s Form 10-K for the year ended June 30, 2020 for more detailed information on the Company’s stock-based compensation plans.

 

During the three months ended March 31, 2021 and 2020, the Company recorded stock option compensation cost of $2,000 and $121,000, respectively, related to stock options that were previously issued. During the nine months ended March 31, 2021 and 2020, the Company recorded stock option compensation cost of $12,000 and $138,000, respectively, related to stock options that were previously issued. As of March 31, 2021, there was a total of $6,000 of unamortized compensation related to stock options which is expected to be recognized over the weighted-average period of 0.92 years.

 

On February 25, 2020, shareholders of the Company voted in favor of amendments to the Company’s 2010 Omnibus Employee Incentive Plan (the “2010 Incentive Plan”) which would amend Section 1.3 of the 2010 Incentive Plan to extend the term from ten (10) years to sixteen (16) years, and Section 6.4 of the 2010 Incentive Plan to change “tenth (10th) anniversary date” to “twentieth (20th) anniversary date”. This would increase the term of the 2010 Incentive Plan to 20 years (expiring in February 2030 instead of February 2020) and also permit the existence of options with a term longer than ten years. The purpose of the amendment to the term is to extend its existence as our only equity incentive plan. The purpose of amendment of the allowable term of options is so that the Board may extend the term of the 100,000 options granted to John Winfield on March 16, 2010 from ten years to sixteen years so that these options will terminate on March 16, 2026 instead of on March 16, 2020, in recognition of Mr. Winfield’s contributions to and leadership of our Company. Upon approval of these amendments by the shareholders, our Board of Directors extended the term of Mr. Winfield’s options as described in this paragraph. As a result of extending Mr. Winfield’s options, the Company recorded stock option compensation cost of $116,000 in March 2020.

 

Option-pricing models require the input of various subjective assumptions, including the option’s expected life and the price volatility of the underlying stock. The expected stock price volatility is based on analysis of the Company’s stock price history. The Company has selected to use the simplified method for estimating the expected term. The risk-free interest rate is based on the U.S. Treasury interest rates whose term is consistent with the expected life of the stock options. No dividend yield is included as the Company has not issued any dividends and does not anticipate issuing any dividends in the future.

 

The following table summarizes the stock options activity from July 1, 2019 through March 31, 2021:

 

        Number of     Weighted Average     Weighted Average   Aggregate  
        Shares     Exercise Price     Remaining Life   Intrinsic Value  
                           
Oustanding at   July 1, 2019     341,195     $ 16.95     3.07 years   $ 4,680,000  
Granted         -       -              
Exercised         -       -              
Forfeited         -       -              
Exchanged         -       -              
Outstanding at   June 30, 2020     341,195     $ 16.95     3.83 years   $ 3,271,000  
Exercisable at   June 30, 2020     323,195     $ 16.38     3.67 years   $ 3,271,000  
Vested and Expected to vest at   June 30, 2020     341,195     $ 16.95     3.83 years   $ 3,271,000  
                                 
Oustanding at   July 1, 2020     341,195     $ 16.95     3.83 years   $ 3,271,000  
Granted         -       -              
Exercised         -       -              
Forfeited         -       -              
Exchanged         -       -              
Outstanding at   March 31, 2021     341,195     $ 16.95     3.08 years   $ 6,689,000  
Exercisable at   March 31, 2021     337,595     $ 16.84     3.05 years   $ 6,656,000  
Vested and Expected to vest at   March 31, 2021     341,195     $ 16.95     3.08 years   $ 6,689,000